Elevance Health (ANTM)
Healthcare · Medical - Healthcare Plans
2 members of Congress have disclosed 6 trades in Elevance Health (ANTM) since 2015: 1 buy and 5 sales. The most recent was disclosed on Aug 7, 2023.
- Trades disclosed
- 6
- Members trading
- 2
- Buys / sells
- 1 / 5
- Reported value
- $34K–$160K
Keep following the company.
Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.
What else is happening at ANTM
All research →Company filings and public records connected to this stock, ordered by when they became public or were first observed.
ANTM: third_quarter 2026 lobbying report
Issues related to Pharmacy Benefit Managers, Medicare Advantage, and health insurance. Issues surrounding risk adjustment. Issues related to Pharmacy Benefit Managers, Medicare Advantage, and health insurance. Issues relating to extension of Enhanced Advanced Premium Tax Credits (EAPTCs) Issues related to No Surprises Act implementation.
Public: Oct 20, 2026, 3:32 PM EDTOriginal source ↗ANTM: third_quarter 2026 lobbying report
Veterans Assuring Critical Care Expansions to Support Servicemembers (ACCESS) Act of 2025 (S. 275 and H.R. 7040) ACA Exchanges & Enrollment Enhanced Premium Tax Credits Prior Authorization Mental Health Parity Facilitating Accountability in Reimbursements Act (FAIR Act) (118th Congress) Site-based Invoicing and Transparency Enhancement (SITE) Act (118th Congress) Health Care Price Certainty for All Americans Act (H.R. 9645) AI Use in Healthcare Health Disparities, including Maternal Health and Rural Health Veterans Affairs Community Cares program The Take Care of Americas Veterans Act (H.R. 92
Public: Oct 20, 2026, 2:52 PM EDTOriginal source ↗ANTM: third_quarter 2026 lobbying report
Federal budget issues Lobbying related to health care access, Medicare, and Medicaid policy Lobbying related to health care access Tax policy Lobbying related to health care access, Medicare, and Medicaid policy
Public: Oct 20, 2026, 2:24 PM EDTOriginal source ↗ANTM: third_quarter 2026 lobbying report
No Surprises Act implementation and health care payment policy.
Public: Oct 20, 2026, 10:13 AM EDTOriginal source ↗ANTM: third_quarter 2026 lobbying report
Issues related to health insurance price transparency. Issues related to prescription drug costs and delivery. Issues related to Surprise Billing. Medicare Advantage, Medicare Part D, Medicaid Managed Care. Issues related to prescription drug costs and delivery. PBM Reform issues. CY 2027 Medicare Advantage Rate Notice. S. 1105 - No UPCODE Act. H.R. 5243 - To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage. H.R. 4093 - Apples to Apples Comparison Act of 2026. Prescription Drug Pricing. Issues related to tax-preferred
Public: Oct 20, 2026, 9:07 AM EDTOriginal source ↗
Who traded ANTM
- Sen. David Perdue (R-GA)1 buy · 4 sales14May 2, 2021
- Sen. John R. Curtis (R-UT)0 buys · 1 sale01Aug 7, 2023
All trades
- Aug 7, 2023$1K–$15K
Rep. John R. Curtis (R-UT)
$1K–$15K · Traded Mar 9, 2022 · disclosed Aug 7, 2023 · Joint · filed 516 days later
- May 2, 2021$15K–$50K
Sen. David Perdue (R-GA)
Sold (full) Elevance Health ANTM
$15K–$50K · Traded Apr 14, 2020 · disclosed May 2, 2021 · Joint · filed 383 days later
- May 8, 2020$15K–$50K
Sen. David Perdue (R-GA)
Sold (full) Elevance Health ANTM
$15K–$50K · Traded Apr 14, 2020 · disclosed May 8, 2020 · Joint
- Nov 5, 2019$1K–$15K
Sen. David Perdue (R-GA)
$1K–$15K · Traded Sep 30, 2019 · disclosed Nov 5, 2019 · Joint
- Mar 6, 2019$1K–$15K
Sen. David Perdue (R-GA)
Sold (partial) Elevance Health ANTM
$1K–$15K · Traded Feb 25, 2019 · disclosed Mar 6, 2019 · Joint
- Jun 26, 2015$1K–$15K
Sen. David Perdue (R-GA)
Sold (partial) Elevance Health ANTM
$1K–$15K · Traded Jun 11, 2015 · disclosed Jun 26, 2015 · Joint
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.